Researchers at King's College London have developed IgE antibodies targeting HER2-expressing cancers. Early studies show ...

Immunotherapy, or antibody treatment that activates the patient's own immune system against cancer, is increasingly being ...

Scientists at King’s College London have developed an innovative IgE antibody therapy that activates the immune system to ...

However, this treatment is not always effective in some patients. Now scientists have investigated a different antibody type, IgE, which activates the patient's immune system in different ways to IgG.

Type I allergy, an IgE antibody triggered hypersensitivity disease, represents a common public health problem affecting about one third of the world´s population. Upon exposure to allergens, IgE ...

A team of scientists is investigating a new type of antibody, which stimulates the immune system to target cancer cells and ...